LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 152 filers reported holding LOXO ONCOLOGY INC in Q3 2017. The put-call ratio across all filers is 1.28 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $28,107,000 | +19.6% | 200,673 | +45.9% | 0.43% | +38.5% |
| Q3 2018 | $23,496,000 | +82.4% | 137,542 | +85.3% | 0.31% | +52.9% |
| Q2 2018 | $12,880,000 | +55.0% | 74,242 | +3.1% | 0.20% | +43.7% |
| Q1 2018 | $8,307,000 | +8.4% | 72,000 | -20.9% | 0.14% | +6.8% |
| Q4 2017 | $7,660,000 | -18.8% | 91,000 | -11.1% | 0.13% | -19.4% |
| Q3 2017 | $9,433,000 | +59.0% | 102,400 | +38.4% | 0.16% | +47.3% |
| Q2 2017 | $5,934,000 | +36.9% | 74,000 | -28.2% | 0.11% | +33.3% |
| Q1 2017 | $4,334,000 | +68.7% | 103,000 | +28.8% | 0.08% | +42.4% |
| Q4 2016 | $2,569,000 | – | 80,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 3,452,493 | $45,330,000 | 8.79% |
| BVF INC/IL | 1,192,202 | $15,654,000 | 3.25% |
| Redmile Group, LLC | 540,300 | $7,094,000 | 0.82% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,591,546 | $20,897,000 | 0.76% |
| Orbimed Advisors | 2,175,857 | $28,569,000 | 0.30% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 365,566 | $4,800,000 | 0.18% |
| MARXE AUSTIN W & GREENHOUSE DAVID M | 75,000 | $985,000 | 0.13% |
| RS INVESTMENT MANAGEMENT CO LLC | 599,400 | $7,870,000 | 0.07% |
| Visium Asset Management, LP | 332,516 | $4,366,000 | 0.06% |
| Nicholas Investment Partners, LP | 73,341 | $963,000 | 0.06% |